1.
J R Soc Med
; 112(11): 472-475, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31526209
RESUMO
A significant loss of bone mineral density and the appearance of multiple vertebral fractures after discontinuation of denosumab treatment have been described. To date, no hip fractures have been reported. We present three cases of patients who suffered femoral fractures after denosumab suppression.